Online Inquiry
Buparlisib (BKM120)
SPC-00464
CAS No. 944396-07-0
Size | Price |
10 mM (1 mL in DMSO) | Online Inquiry |
5 mg | Online Inquiry |
10 mg | Online Inquiry |
50 mg | Online Inquiry |
Bulk Size | Online Inquiry |
PI3K inhibitor ; Apoptosis related activator
Description |
---|
Buparlisib (BKM120, NVP-BKM120) is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM in cell-free assays, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4Kβ. Buparlisib induces apoptosis. Phase 2. |
Product Details | |
---|---|
CAS No. | CAS No. 944396-07-0 |
Description | Buparlisib (BKM120, NVP-BKM120) is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM in cell-free assays, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4Kβ. Buparlisib induces apoptosis. Phase 2. |
Formula | C18H21F3N6O2 |
Molecular Weight | 410.39 |
Storage | 3 years -20°C powder 2 years -80°C in solvent |
Synonyms | NVP-BKM120 |
SMILES | C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4 |
Solubility | DMSO |
Usage | |
---|---|
Storage | 3 years -20°C powder 2 years -80°C in solvent |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.